Skip to main content
SpringerLink
Log in

Folate Receptor-Mediated Liposomal Delivery of a Lipophilic Boron Agent to Tumor Cells in Vitro for Neutron Capture Therapy

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. This study was aimed at the in vitro evaluations of folate receptor (FR)-targeted liposomes as carriers for a lipophilic boron agent, K[nido-7-CH3(CH2)15-7,8-C2B9H11], in FR-overexpressing tumor cells for neutron capture therapy.

Methods. Large unilamellar vesicles (∼200 nm in diameter) were prepared with the composition of egg PC/chol/K[nido-7-CH3(CH2)15-7,8-C2B9H11] (2:2:1, mol/mol), with an additional 0.5 mol % of folate-PEG-DSPE or PEG-DSPE added for the FR-targeted or nontargeted liposomal formulations, respectively.

Results. Boron-containing, FR-targeted liposomes readily bound to KB cells, an FR-overexpressing cell line, and were internalized via FR-mediated endocytosis. The boron uptake in cells treated with these liposomes was approximately 10 times greater compared with those treated with control liposomes. In contrast, FR-targeted and nontargeted liposomes showed no difference in boron delivery efficiency in F98 cells, which do not express the FR. The subcellular distribution of the boron compound in KB cells treated with the FR-targeted liposomes was investigated by cellular fractionation experiments, which showed that most of the boron compound was found in either the cytosol/endosomal or cell membrane fractions, indicating efficient internalization of the liposomal boron.

Conclusion. FR-targeted liposomes incorporating the lipophilic boron agent, K[nido-7-CH3(CH2)15-7,8-C2B9H11], into its bilayer were capable of specific receptor binding and receptor-mediated endocytosis in cultured KB cells. Such liposomes warrant further investigations for use in neutron capture therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. P. Garin-Chesa, I. Campbell, P. Saigo, J. Lewis, L. Old, and W. Rettig. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am.J.Pathol. 142:557-567 (1993).

    Google Scholar 

  2. S. D. Weitman, R. H. Lark, L. R. Coney, D. W. Fort, V. Frasca, V. R. J. Zurawski, and B. A. Kamen. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52:3396-3401 (1992).

    Google Scholar 

  3. X. Wang, F. Shen, J. H. Freisheim, L. E. Gentry, and M. Ratnam. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem.Pharmacol. 44:1898-1901 (1992).

    Google Scholar 

  4. C. P. Leamon and P. S. Low. Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis. Proc.Natl.Acad.Sci.USA 88:5572-5576 (1991).

    Google Scholar 

  5. J. J. Sudimack and R. J. Lee. Targeted drug delivery via the folate receptor. Adv.Drug Deliv.Rev. 41:147-162 (2000).

    Google Scholar 

  6. M. A. Gosselin and R. J. Lee. Folate receptor-targeted liposomes as vectors for therapeutic agents. In M. R. El-Gewely (ed.), Biotechnology Annual Review, Elsevier Science B. V., Amsterdam, 2002, pp. 103-131 (in press).

    Google Scholar 

  7. R. F. Barth, A. H. Soloway, R. G. Fairchild, and R. M. Brugger. Boron neutron capture therapy for cancer. Cancer 70:2995-3007 (1992).

    Google Scholar 

  8. R. F. Barth, A. H. Soloway, and R. G. Fairchild. Boron neutron capture therapy for cancer. Cancer Res. 50:1061-1070 (1990).

    Google Scholar 

  9. S. C. Mehta and D. R. Lu. Targeted drug delivery for boron neutron capture therapy. Pharm.Res. 13:344-351 (1996).

    Google Scholar 

  10. M. Johnsson, N. Bergstrand, and K. Edwards. Optimization of drug loading procedures and characterization of liposomal formulations of two novel agents intended for boron neutron capture therapy (BNCT). J.Liposome Res. 9:53-79 (1999).

    Google Scholar 

  11. K. Shelly, D. A. Feakes, M. F. Hawthorne, P. G. Schmidt, T. A. Krisch, and W. F. Bauer. Model studies directed toward the boron neutron-capture therapy of cancer: Boron delivery to murine tumors with liposomes. Proc.Natl.Acad.Sci.USA 89:9039-9043 (1992).

    Google Scholar 

  12. D. A. Feakes, K. Shelly, C. B. Knobler, and M. F. Hawthorne. Na3[B20H17NH3]: Synthesis and liposomal delivery to murine tumors. Proc.Natl.Acad.Sci.USA 91:3029-3033 (1994).

    Google Scholar 

  13. D. A. Feakes, K. Shelly, and M. F. Hawthorne. Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes. Proc.Natl.Acad.Sci.USA 92:1367-1370 (1995).

    Google Scholar 

  14. N. Bergstrand, E. Bohl, J. Carlsson, K. Edwards, H. Ghaneolhosseini, L. Gedda, M. Johnsson, M. Silvander, and S. Sjöberg. Stabilized liposomes with double targeting for use in BNCT. In M. Davidson, A. K. Hughes, T. B. Marder, and K. Wade (eds.), Contemporary Boron Chemistry, Royal Society of Chemistry, Cambridge, 2000, pp. 131-134.

    Google Scholar 

  15. M. F. Hawthorne and K. Shelly. Liposomes as drug delivery vehicles for boron agents. J.Neurooncol. 33:53-58 (1997).

    Google Scholar 

  16. Y. Setiawan, D. E. Moore, and B. J. Allen. Selective uptake of boronated low-density lipoprotein in melanoma xenografts achieved by diet supplementation. Br.J.Cancer 74:1705-1708 (1996).

    Google Scholar 

  17. B. H. Laster, S. B. Kahl, E. A. Popenoe, D. W. Pate, and R. G. Fairchild. Biologic efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture. Cancer Res. 51:4588-4593 (1991).

    Google Scholar 

  18. H. Yanagie, T. Tomita, H. Kobayashi, Y. Fujii, Y. Nonaka, Y. Seagusa, K. Hasumi, M. Eriguchi, T. Kobayashi, and K. Ono. Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy. Br.J.Cancer 75:660-665 (1997).

    Google Scholar 

  19. L. Liu, R. F. Barth, D. M. Adams, A. H. Soloway, and R. A. Reisfeld. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. Anticancer Res. 16:2581-2587 (1996).

    Google Scholar 

  20. R. F. Barth, D. M. Adams, A. H. Soloway, F. Alam, and M. V. Darby. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy. Bioconjug.Chem. 5:58-66 (1994).

    Google Scholar 

  21. H. Yanagie, Y. Fujii, M. Sekiguchi, H. Nariuchi, T. Kobayashi, and K. Kanda. A targeting model of boron neutron-capture therapy to hepatoma cells in vivo with a boronated anti-(alpha-fetoprotein) monoclonal antibody. J.Cancer Res.Clin.Oncol 120:636-640 (1994).

    Google Scholar 

  22. P. Olsson, L. Gedda, H. Goike, L. Liu, V. P. Collins, J. Ponten, and J. Carlsson. Uptake of a boronated epidermal growth factordextran conjugate in CHO xenografts with and without human EGF-receptor expression. Anticancer Drug Des. 13:279-289 (1998).

    Google Scholar 

  23. W. Yang, R. F. Barth, D. M. Adams, and A. H. Soloway. Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors. Cancer Res. 57:4333-4339 (1997).

    Google Scholar 

  24. L. Gedda, P. Olsson, J. Ponten, and J. Carlsson. Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy. Bioconjug.Chem. 7: 584-591 (1996).

    Google Scholar 

  25. D. W. Deamer and P. S. Uster. Liposome preparation: Methods and mechanisms. In M. J. Ostro (ed.), Liposomes, Dekker, New York, 1983, pp. 27-51.

    Google Scholar 

  26. R. J. Lee and P. S. Low. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim.Biophys.Acta 1233:134-144 (1995).

    Google Scholar 

  27. W. Guo, T. Lee, J. J. Sudimack, and R. J. Lee. Receptor-specific delivery of liposomes via folate-PEG-chol. J.Liposome Res. 10: 179-195 (2000).

    Google Scholar 

  28. R. F. Barth, D. M. Adams, A. H. Soloway, E. B. Mechetner, F. Alam, and A. K. Anisuzzaman. Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy. Anal.Chem. 63:890-893 (1991).

    Google Scholar 

  29. R. P. Sharma and I. R. Edwards. cis-Platinum: Subcellular distribution and binding to cytosolic ligands. Biochem.Pharmacol. 32: 2565-2669 (1983).

    Google Scholar 

  30. D. Gabel, S. Foster, and R. G. Fairchild. The Monte Carlo simulation of the biologic effect of the 10B(n, α)7Li reaction in cells and tissue and its implication for boron neutron capture therapy. Radiat.Res. 111:14-25 (1987).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, Rm. 542 LM Parks Hall, The Ohio State University, 500 W. 12th Avenue, Columbus, Ohio, 43210

    Jennifer J. Sudimack, Supriya Shukla, Junhua Yan, Masaru Sekido, Werner Tjarks & Robert J. Lee

  2. College of Medicine and Public Health, The Ohio State University, Columbus, Ohio, 43210

    Dianne Adams, Joan Rotaru & Rolf F. Barth

Authors
  1. Jennifer J. Sudimack
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dianne Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joan Rotaru
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Supriya Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Junhua Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masaru Sekido
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rolf F. Barth
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Werner Tjarks
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Robert J. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert J. Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sudimack, J.J., Adams, D., Rotaru, J. et al. Folate Receptor-Mediated Liposomal Delivery of a Lipophilic Boron Agent to Tumor Cells in Vitro for Neutron Capture Therapy. Pharm Res 19, 1502–1508 (2002). https://doi.org/10.1023/A:1020408716807

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020408716807

Search

Navigation